-
TRUSTED AU LABORATORY
-
26 Mark Rd. Elizabeth South, SA - 5112
-
Same day delivery
Pull the syringe to:
(0.100ml)
This calculator is provided as a reference tool for research purposes only. Always follow your institution’s safety protocols when handling research compounds.
HGH 10iu peptide refers to a human growth hormone research reference product commonly associated with somatropin pathway research. Somatropin is recombinant human growth hormone, a 191-amino-acid protein with a molecular weight of approximately 22,125 daltons. DailyMed describes somatropin as human growth hormone produced by recombinant DNA technology using Escherichia coli.
This product page must be handled carefully because “HGH” and “10IU” are strongly associated with regulated medicine use and human administration. Information on this page is provided for laboratory research context, identity discussion, pathway education and compliance framing only.
This product is not supplied for human or animal consumption, administration, injection, hormone therapy, bodybuilding, anti-ageing, fat loss, recovery, performance enhancement or general wellness use.
| Product Detail | Information |
|---|---|
| Product name | HGH 10IU |
| Common research name | Human growth hormone |
| Pharmacological name | Somatropin |
| Product type | Growth hormone research reference product |
| Measurement shown | 10IU |
| Main research category | Endocrine Research / Growth Hormone Pathway Research |
| Common research interest | Growth hormone receptor, IGF-1 pathway, endocrine signalling and protein hormone research |
| Protein type | Recombinant human growth hormone where identity is confirmed |
| Approximate structure | 191-amino-acid protein |
| Approximate molecular weight | 22,125 daltons |
| Intended use | Laboratory research reference only |
| Human use | Not for human consumption, administration, hormone therapy or injection |
| Documentation | Certificate of Analysis and supplier documentation must be checked before use |
| Component | Research Class | General Research Role |
| Human growth hormone | Protein hormone | Studied in relation to endocrine signalling and growth hormone receptor research |
| Somatropin | Recombinant human growth hormone | Pharmaceutical name used for approved recombinant HGH medicines |
| 191-amino-acid protein | Protein sequence structure | Common structure listed for somatropin |
| Growth hormone receptor pathway | Endocrine receptor pathway | Studied in GH receptor signalling models |
| IGF-1 pathway | Downstream endocrine pathway | Studied as part of GH axis and endocrine signalling research |
| Lyophilised or solution format | Supplier-specific | Must be confirmed through product documentation and CoA |
Product identity, purity, biological activity, formulation, excipients, sterility status, storage conditions and batch information must be confirmed through the Certificate of Analysis and supplier documentation. The product name alone is not enough to verify quality, identity or suitability for any research protocol.
HGH is studied in relation to the growth hormone receptor pathway. In approved medicine labels, somatropin is described as binding to dimeric GH receptors on target tissue cell membranes, leading to intracellular signal transduction. This pathway is commonly connected to downstream IGF-1 signalling and endocrine research models.
In laboratory and endocrine research contexts, HGH may be discussed in relation to:
| Research Area | Research Context |
| Growth hormone receptor signalling | GH receptor pathway and intracellular signalling models |
| IGF-1 pathway research | Downstream growth hormone axis research |
| Endocrine pathway studies | Hormone signalling and regulatory pathway models |
| Protein hormone research | Recombinant hormone structure and activity research |
| Cellular response models | GH receptor expression and response models |
| Comparative research | Comparison with GHRH analogues and GH secretagogue pathway products |
This research context must not be turned into human-use claims. A research reference product is not equivalent to a registered medicine and should not be marketed as a treatment, hormone replacement product or performance product.
| Research Area | HGH / Somatropin |
| Main research category | Protein hormone research |
| Common name | Human growth hormone |
| Pharmacological name | Somatropin |
| Approximate length | 191 amino acids |
| Approximate molecular weight | 22,125 daltons |
| Main receptor interest | Growth hormone receptor |
| Downstream research interest | IGF-1 and endocrine pathway signalling |
| Regulatory context | Approved somatropin medicines exist, but research products are not equivalent to approved medicines |
| Product limitation | Research reference only, not approved for human use |
| Feature | HGH | CJC-1295 |
| Research class | Growth hormone protein | GHRH analogue research peptide |
| Main pathway | Growth hormone receptor pathway | Growth hormone-releasing hormone receptor pathway |
| Position in GH axis | Direct GH receptor research | Upstream GHRH pathway research |
| Structure | 191-amino-acid protein hormone | Shorter peptide analogue |
| Common SEO risk | Human hormone therapy, bodybuilding, anti-ageing and performance claims | GH boosting, anti-ageing and bodybuilding claims |
| Safer positioning | Somatropin pathway research reference | GHRH analogue research peptide |
| Feature | HGH | Tesamorelin |
| Research class | Growth hormone protein | GHRH analogue research peptide |
| Main pathway | GH receptor pathway | GHRH receptor pathway |
| Research position | Direct hormone pathway research | Upstream hormone-releasing pathway research |
| Common downstream interest | IGF-1 pathway models | GH and IGF-1 pathway models |
| Human-use risk | Hormone therapy and performance misuse | Fat loss and metabolic treatment misuse |
| Safer positioning | Somatropin research reference | GHRH analogue research peptide |
| Feature | HGH | Ipamorelin |
| Research class | Protein hormone | Growth hormone secretagogue research peptide |
| Main pathway | GH receptor signalling | Ghrelin receptor / GHSR pathway research |
| GH axis position | Direct hormone pathway research | Secretagogue pathway research |
| Structure | Larger protein hormone | Short synthetic peptide |
| Human-use risk | Hormone therapy, performance and anti-ageing misuse | GH boosting and bodybuilding misuse |
| Safer positioning | Growth hormone receptor research reference | GHSR pathway research peptide |
| Product | Safer Research Positioning |
| HGH 10IU | Somatropin and GH receptor pathway research reference |
| CJC-1295 No DAC | Modified GRF 1-29 and GHRH receptor pathway research |
| CJC-1295 with DAC | Longer-acting GHRH analogue research |
| Ipamorelin | GHSR and growth hormone secretagogue pathway research |
| Tesamorelin | GHRH analogue and metabolic pathway research |
| AOD-9604 | hGH fragment pathway research |
These pages should not be written as if they are interchangeable. HGH is a protein hormone, while CJC-1295, Tesamorelin, Ipamorelin and AOD-9604 relate to different research pathways or fragments.
| Common Online Claim | Safer Research-Use Wording |
| Muscle growth | Not an approved or appropriate product claim |
| Fat loss | Not an approved or appropriate product claim |
| Anti-ageing | Not an approved or appropriate product claim |
| Recovery | Not an approved or appropriate product claim |
| Sleep support | Not an approved or appropriate product claim |
| Performance enhancement | Not an approved or appropriate product claim |
| Height growth | Not appropriate for a research product page |
| Hormone replacement | Only relevant to approved prescription medicines under medical supervision |
| GH receptor signalling | Suitable research pathway wording |
| IGF-1 pathway research | Suitable laboratory pathway wording |
HGH 10IU is not intended to diagnose, treat, cure or prevent any disease. It is not supplied for growth hormone deficiency, height growth, hormone replacement therapy, muscle growth, fat loss, anti-ageing, recovery, sleep, energy, bodybuilding, athletic performance, body transformation or general wellness use.
All information on this page is provided for laboratory research reference and product handling context only.
No dilution recommendation is provided for HGH 10IU.
Because this product is described using IU, and because HGH is a regulated protein hormone associated with prescription medicine use and human administration, this page does not provide dilution ratios, reconstitution amounts, concentration tables or vial preparation instructions.
Any legitimate laboratory handling must be based on supplier documentation, Certificate of Analysis, validated institutional protocol and qualified laboratory oversight.
For many research peptides, a simple concentration table can be provided using the formula:
Total peptide amount divided by diluent volume equals final concentration.
That approach is not appropriate for this HGH 10IU page because:
| Reason | Explanation |
| IU is a biological activity unit | It is not the same as a simple milligram amount |
| HGH is a regulated protein hormone | Human-use risk is higher than standard research catalogue products |
| Approved medicines have product-specific instructions | Those instructions are not transferable to research products |
| Reconstitution amounts may be misused | They could be interpreted as human injection guidance |
| Formulation matters | Excipients, protein form, sterility and activity must be verified by documentation |
| Compliance risk is high | Public dilution guidance may encourage unsafe or unlawful use |
Before handling any HGH 10IU research reference product in a laboratory setting, make sure all materials, documentation and approvals are prepared.
| Item | Purpose |
| Product container | Contains HGH / somatropin research reference material |
| Certificate of Analysis | Confirms batch-level testing information |
| SDS or safety documentation | Provides handling, hazard and disposal guidance |
| Identity documentation | Helps verify whether the product is somatropin or another GH-related material |
| Biological activity information | Helps interpret IU-based labelling where provided |
| Qualified laboratory protocol | Required before any preparation or handling |
| Personal protective equipment | Gloves, lab coat and eye protection |
| Laboratory labels | Records product identity, batch, date and handler details |
| Controlled storage access | Supports correct storage according to documentation |
| Disposal container | Used for compliant laboratory waste disposal |
This page does not provide reconstitution instructions for HGH 10IU.
The following is a general documentation and compliance framework only.
Check the product label, batch number, Certificate of Analysis, SDS, identity documentation, storage requirements and activity unit information before handling.
Ensure the product is being handled only under an approved laboratory protocol and in compliance with applicable Australian laws, institutional requirements and supplier restrictions.
Use a suitable laboratory workspace. Wear appropriate PPE and follow institutional procedures for handling protein hormone reference materials.
Do not use bodybuilding forums, social media content, clinic protocols, medicine labels or online dosing calculators to prepare HGH 10IU.
Any preparation must follow the validated research protocol and supplier documentation. Public product-page content should not replace laboratory procedures.
Label all research materials with product identity, batch number, date, handler, storage condition and protocol reference.
Store according to supplier documentation and approved laboratory protocol. Avoid unnecessary temperature cycling, light exposure or uncontrolled handling.
Dispose of all waste according to laboratory and institutional waste procedures.
HGH products are especially vulnerable to naming, quality and regulatory confusion.
| Issue | What It May Indicate | Safer Response |
| Product says “HGH 10IU” but no CoA | Identity and activity cannot be verified | Do not use until documentation is provided |
| Product does not specify somatropin | Material may not be clearly identified | Confirm identity before handling |
| Product gives body-use instructions | Compliance and safety risk | Remove instructions and do not rely on them |
| Product uses bodybuilding language | Misleading human-use positioning | Rewrite as research reference only |
| Product is compared to registered medicines | May imply therapeutic equivalence | Separate research material from approved medicine context |
| Product has no storage data | Stability cannot be confirmed | Check supplier documentation before handling |
| Storage Factor | Guidance |
| Product form | Supplier-specific protein hormone reference material |
| Storage condition | Follow supplier label, CoA and SDS |
| Light exposure | Protect from unnecessary light exposure |
| Moisture exposure | Keep sealed until use |
| Temperature changes | Avoid repeated temperature cycling |
| Documentation | Store with CoA and batch traceability |
| Handling | Minimise unnecessary opening and exposure |
This page does not provide post-reconstitution storage instructions for HGH 10IU.
Any prepared research material must be stored according to supplier documentation, institutional protocol and validated laboratory procedures. Public product-page content should not be used to determine storage times, use-by periods, sterility assumptions or preparation suitability.
This page does not provide human dosing, injection instructions, injection schedules, reconstitution instructions, IU conversion, administration guidance or hormone therapy guidance.
HGH 10IU is not supplied for human or animal administration. It is a research reference product only.
Approved somatropin medicines have product-specific prescribing information, medical supervision requirements, formulation details and regulatory controls. Those instructions are not transferable to research-use HGH 10IU products, different suppliers, non-approved products or public e-commerce listings.
| Planning Item | What to Record |
| Product identity | HGH, somatropin or other GH-related material |
| Activity unit | IU information as stated by supplier documentation |
| Batch details | Product batch, CoA and preparation date |
| Testing method | Identity, purity and activity method where available |
| Storage location | Fridge, freezer or other controlled storage area |
| Handler details | Researcher name or initials |
| Protocol reference | Approved research protocol number or document |
| Preparation status | Not prepared, prepared under protocol or quarantined |
| Disposal date | When the material should no longer be used |
| Compliance check | Confirmation that no human-use claims are attached to the product page |
Correct handling is important for research consistency, traceability, protein stability and compliance. Most mistakes occur when HGH is marketed with bodybuilding, anti-ageing, recovery or fat loss language, or when public product pages provide reconstitution details that can be interpreted as injection guidance.
HGH is also relevant to anti-doping compliance. Sport Integrity Australia states that human growth hormone is listed on the WADA Prohibited List under peptide hormones, growth factors, related substances and mimetics, and is prohibited at all times in and out of competition.
| Always | Why It Matters |
| Check the Certificate of Analysis | Confirms batch-level information |
| Confirm identity as HGH or somatropin | Prevents product confusion |
| Review SDS or safety documentation | Supports safe laboratory handling and disposal |
| Confirm regulatory status | HGH is a high-risk regulated hormone context |
| Use PPE | Reduces contamination and exposure risk |
| Label every container | Prevents mix-ups |
| Keep batch records | Supports traceability |
| Follow institutional protocol | Keeps handling consistent and auditable |
| Store according to documentation | Helps protect protein stability |
| Dispose of waste correctly | Supports safety and compliance |
| Use research-reference wording only | Reduces misleading human-use interpretation |
| Avoid all human benefit claims | Prevents unsafe and non-compliant product positioning |
| Never | Why It Is Risky |
| Never use for self-injection | Product is not supplied for human use |
| Never provide public reconstitution instructions | Could be misused as administration guidance |
| Never sell or promote as hormone therapy | HGH is a regulated medicine context |
| Never market as bodybuilding support | Creates human-use and anti-doping risk |
| Never make muscle growth claims | Not appropriate for a research-use product page |
| Never make fat loss claims | Not appropriate for a research-use product page |
| Never make anti-ageing claims | Not appropriate for a research-use product page |
| Never make recovery or performance claims | Creates safety and anti-doping risk |
| Never imply equivalence to approved somatropin medicines | Misleading and clinically inappropriate |
| Never assume IU conversion without documentation | IU is activity-based and product-specific |
| Never use a damaged or unlabelled container | Identity and integrity may be uncertain |
| Never rely on social media or clinic protocols | They may be unsafe, inaccurate or non-compliant |
No alternative reconstitution amounts are provided for HGH 10IU.
This is intentional. Public concentration tables, IU conversion tables or preparation examples for HGH may be misused as human dosing or injection guidance. Any legitimate laboratory work must rely on qualified protocols and supplier documentation only.
No quick concentration example is provided for HGH 10IU.
Because the product is described in IU and relates to a regulated hormone, public conversion or dilution examples are not appropriate for this page.
HGH stands for human growth hormone. In regulated medicine contexts, recombinant human growth hormone is commonly called somatropin. Somatropin is described as a 191-amino-acid human growth hormone produced by recombinant DNA technology.
IU means international units. It is an activity-based unit, not a simple mass unit like milligrams. This page does not provide IU conversion, dilution or administration calculations.
In regulated medicine contexts, somatropin refers to recombinant human growth hormone. Product identity for any research reference material must still be confirmed through CoA and supplier documentation.
Approved somatropin medicines exist in Australia, and the PBS lists human growth hormone medicines under a restricted Growth Hormone Program. This does not make a research-use HGH 10IU product approved for human use.
No. HGH should not be promoted for bodybuilding, performance, recovery, fat loss or athletic use. Human growth hormone is prohibited at all times under anti-doping rules.
No. This product page should not make anti-ageing, wellness, energy, recovery, body transformation or longevity claims. Any such wording creates unsafe and non-compliant human-use positioning.
No dilution table is provided because HGH is a regulated protein hormone and the product is labelled in IU. Public dilution guidance could be misused as injection or dosing guidance.
A Certificate of Analysis provides batch-level testing information. For HGH, it is especially important because identity, purity, biological activity, formulation, sterility assumptions and storage requirements cannot be assumed from the product name alone.
| Resource | Why It Is Useful |
| DailyMed Humatrope somatropin label | Useful background on somatropin as recombinant human growth hormone, including protein structure and GH receptor pathway context. |
| TGA ARTG Omnitrope somatropin entry | Useful Australian regulatory context showing approved somatropin medicines exist as registered medicines. |
| PBS Growth Hormone Program | Useful Australian context showing growth hormone access is clinically restricted under the PBS program. |
Research Reference Only: HGH 10IU is supplied strictly for permitted laboratory research reference purposes only, where lawful and supported by appropriate documentation. It is not intended for human or animal consumption, injection, infusion, therapeutic use, diagnostic use, hormone therapy, growth hormone deficiency treatment, height growth, muscle growth, fat loss, recovery, anti-ageing, bodybuilding, athletic performance, body enhancement or general wellness use. This page does not provide dosing, dilution, reconstitution, injection, administration or IU conversion guidance. Always follow applicable laws, institutional procedures, supplier documentation, SDS guidance and qualified laboratory protocols.
